Malignant Peripheral Nerve Sheath Tumor
📧 Sign up to get email alerts when something new happens for Malignant Peripheral Nerve Sheath Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 [Phase 1]
A Phase 1 trial investigating the transformation of plexiform neurofibromas into malignant peripheral nerve sheath tumors in Neurofibromatos…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor [Phase 1, Phase 2]
This clinical trial update reports on the safety and efficacy evaluation of the investigational agent BMS-986504 in unresectable malignant p…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Tazemetostat in Malignant Peripheral Nerve Sheath Tumors [Phase 2]
Phase 2 trial results for tazemetostat in malignant peripheral nerve sheath tumors have been posted, and the study is currently not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion [Phase 1]
Bristol-Myers Squibb is conducting a Phase 1 trial of MRTX1719 in MTAP-deleted solid tumors, including mesothelioma, non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor [Phase 1]
Phase 1 study evaluating neoadjuvant nivolumab plus ipilimumab for newly diagnosed malignant peripheral nerve sheath tumor. The trial status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults [Phase 2]
A Phase 2 trial evaluating donor stem cell transplant after chemotherapy for recurrent or refractory high-risk solid tumors in pediatric and…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients [Phase 1]
Phase 1 study evaluating different dosing schedules of Selinexor in soft tissue sarcoma and related tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors [Phase 1, Phase 2]
The trial investigated PLX3397 plus sirolimus in unresectable sarcoma and malignant peripheral nerve sheath tumor; the study was terminated,…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery [Phase 1]
This Phase 1 clinical trial evaluated a vaccine therapy for malignant peripheral nerve sheath tumors that are metastatic, recurrent, or unre…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors [Phase 2]
Phase 2 clinical trial evaluating MEK inhibitor selumetinib plus mTOR inhibitor sirolimus for malignant peripheral nerve sheath tumors (MPNS…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma [Phase 2]
Phase 2 trial update for Lorvotuzumab Mertansine in several relapsed/refractory pediatric solid tumors; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy for stage III/IV malignant peripheral nerve sheath tumors in patients with Neurof…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating HSV-1716 in patients with non-CNS solid tumors, including rhabdomy…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor [Phase 2]
A Phase 2 trial of erlotinib for unresectable or metastatic malignant peripheral nerve sheath tumor has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Alisertib in Treating Patients With Advanced or Metastatic Sarcoma [Phase 2]
A Phase 2 trial update of alisertib in patients with advanced or metastatic soft tissue sarcomas, including myxofibrosarcoma and several his…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine and docetaxel with pazopanib for neoadjuvant treatment in soft tissue sarcoma was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy [NA]
Completed clinical trial evaluating the effects of preoperative physical therapy in patients with lower extremity bone sarcomas; results are…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Sorafenib and Dacarbazine in Soft Tissue Sarcoma [Phase 2]
A Phase 2 study evaluating the combination of sorafenib and dacarbazine in soft tissue sarcoma reported completed results in 2015, including…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]
Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.